Unknown

Dataset Information

0

ATNT-10DOES VALPROIC ACID IMPROVE SURVIVAL IN GLIOBLASTOMA? A META-ANALYSIS OF RANDOMIZED TRIALS IN NEWLY DIAGNOSED GLIOBLASTOMA

ABSTRACT:

SUBMITTER: Happold C 

PROVIDER: S-EPMC4638532 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
| S-EPMC5070573 | biostudies-literature
Unknown Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 newly diagnosed disease.
| S-EPMC8134529 | biostudies-literature
Unknown The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials.
| S-EPMC5179058 | biostudies-literature
Unknown Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.
| S-EPMC5464324 | biostudies-literature
Unknown A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma.
| S-EPMC7201711 | biostudies-literature
Unknown A randomized trial of bevacizumab for newly diagnosed glioblastoma.
| S-EPMC4201043 | biostudies-literature
Unknown Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.
| S-EPMC10558397 | biostudies-literature
Unknown Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.
| S-EPMC12563183 | biostudies-literature
Unknown Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
| S-EPMC7914075 | biostudies-literature
Unknown Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
| S-EPMC6374760 | biostudies-literature